• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腮腺腺样囊性癌:单机构回顾性分析。

Parotid adenoid cystic carcinoma: Retrospective single institute analysis.

作者信息

Mannelli Giuditta, Cecconi Lorenzo, Fasolati Martina, Santoro Roberto, Franchi Alessandro, Gallo Oreste

机构信息

Otorhinolaryngology-Head and Neck Surgery Unit, Department of Surgery and Translational Medicine, University of Florence, AOU-Careggi, Via Largo Palagi 1, 50134 Florence, Italy.

Department of Statistic, Computer Science, Application, University of Florence, Italy.

出版信息

Am J Otolaryngol. 2017 Jul-Aug;38(4):394-400. doi: 10.1016/j.amjoto.2017.03.008. Epub 2017 Mar 31.

DOI:10.1016/j.amjoto.2017.03.008
PMID:28478090
Abstract

PURPOSE

Adenoid cystic carcinoma (ACC) is a uncommon salivary malignant tumor. Our aim was to review our experience with parotid ACC, to identify clinical-pathological parameters predictive for outcome.

MATERIALS AND METHODS

We retrospectively reviewed 228 patients affected by parotid gland carcinomas surgically treated at our Institution. Forty-four ACC were included in this study. Multivariate analysis risk models were built to predict recurrence free probability (RFP), distant recurrence free probability (DRFP), overall survival (OS) and disease free survival (DFS).

RESULTS

Twenty-one patients (47.7%) died from ACC and 2.3% for other causes. The 41% presented local-regional recurrence, with a regional-RFP rate of 93%, and the 34% reported distant metastases (DM). The five and ten-year OS rates were 74% and 50%, respectively.

CONCLUSIONS

Recurrences were mainly influenced by the presence of perineural invasion and nerve paralysis, whilst female gender and age<50 were predictors for good prognosis.

摘要

目的

腺样囊性癌(ACC)是一种罕见的涎腺恶性肿瘤。我们的目的是回顾我们治疗腮腺ACC的经验,以确定预测预后的临床病理参数。

材料与方法

我们回顾性分析了在我院接受手术治疗的228例腮腺癌患者。本研究纳入了44例ACC患者。构建多变量分析风险模型以预测无复发生存概率(RFP)、无远处复发生存概率(DRFP)、总生存期(OS)和无病生存期(DFS)。

结果

21例患者(47.7%)死于ACC,2.3%死于其他原因。41%出现局部区域复发,区域RFP率为93%,34%报告有远处转移(DM)。5年和10年总生存率分别为74%和50%。

结论

复发主要受神经周围浸润和神经麻痹的影响,而女性和年龄<50岁是预后良好的预测因素。

相似文献

1
Parotid adenoid cystic carcinoma: Retrospective single institute analysis.腮腺腺样囊性癌:单机构回顾性分析。
Am J Otolaryngol. 2017 Jul-Aug;38(4):394-400. doi: 10.1016/j.amjoto.2017.03.008. Epub 2017 Mar 31.
2
[Adenoid cystic carcinoma of the head and neck--a 10 years experience].[头颈部腺样囊性癌——十年经验]
Otolaryngol Pol. 2011 Sep;65(5 Suppl):6-11. doi: 10.1016/S0030-6657(11)70702-8.
3
Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.预测腺样囊性癌患者生存和复发的列线图。一项国际合作研究。
Eur J Cancer. 2015 Dec;51(18):2768-76. doi: 10.1016/j.ejca.2015.09.004. Epub 2015 Nov 19.
4
The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan.临床病理因素对涎腺腺样囊性癌患者临床结局的影响:日本多机构分析。
Int J Clin Oncol. 2020 Oct;25(10):1774-1785. doi: 10.1007/s10147-020-01731-9. Epub 2020 Jul 1.
5
Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.丹尼尔·丹霍德癌症中心 186 例原发性腮腺癌患者手术联合放疗的长期疗效及生活质量。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):189-95. doi: 10.1016/j.ijrobp.2011.11.045. Epub 2012 Feb 11.
6
Prognostic Factors and Clinical Outcome in Parotid Gland Tumors: a Single Institution Experience from the Eastern Black Sea Region of Turkey.腮腺肿瘤的预后因素及临床结局:来自土耳其黑海东部地区一家机构的经验
Asian Pac J Cancer Prev. 2016;17(3):1169-74. doi: 10.7314/apjcp.2016.17.3.1169.
7
Survival in patients with parotid gland carcinoma - Results of a multi-center study.腮腺癌患者的生存情况——一项多中心研究的结果
Am J Otolaryngol. 2018 Jan-Feb;39(1):65-70. doi: 10.1016/j.amjoto.2017.10.012. Epub 2017 Oct 24.
8
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation.手术联合放疗治疗头颈部腺样囊性癌时切缘阳性及神经侵犯的影响
Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):619-26. doi: 10.1016/0360-3016(95)00122-F.
9
Surgical management of adenoid cystic carcinoma in the parotid gland.腮腺腺样囊性癌的外科治疗
Otolaryngol Head Neck Surg. 1992 Apr;106(4):332-8. doi: 10.1177/019459989210600403.
10
Intraoral adenoid cystic carcinoma: prognostic factors and outcome.口腔内腺样囊性癌:预后因素与结局
Oral Oncol. 2008 Oct;44(10):986-93. doi: 10.1016/j.oraloncology.2008.01.004. Epub 2008 Mar 7.

引用本文的文献

1
Adenoid Cystic Carcinoma of Salivary Glands: A Ten-Year Review and an Assessment of the Current Management, Surgery, Radiotherapy, and Chemotherapy.涎腺腺样囊性癌:十年回顾及当前治疗、手术、放疗和化疗评估
Int J Otolaryngol. 2023 Apr 29;2023:7401458. doi: 10.1155/2023/7401458. eCollection 2023.
2
Occult neck metastases risk factors and the role of elective neck dissection in cT3-4N0 adenoid cystic carcinoma of the parotid gland.腮腺cT3-4N0腺样囊性癌的隐匿性颈部转移危险因素及选择性颈部清扫术的作用
Front Oncol. 2022 Sep 26;12:935110. doi: 10.3389/fonc.2022.935110. eCollection 2022.
3
Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period.
20 年来波兰最常见腮腺癌的临床流行病学分析。
Int J Environ Res Public Health. 2022 Aug 18;19(16):10247. doi: 10.3390/ijerph191610247.
4
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review.评估复发性涎腺癌挽救性手术后的生存情况:系统评价。
Head Neck. 2022 Aug;44(8):1961-1975. doi: 10.1002/hed.27062. Epub 2022 Apr 20.
5
Establishment and Validation of Prognostic Nomograms for Patients With Parotid Gland Adenocarcinoma Not Otherwise Specified: A SEER Analysis From 2004 to 2016.未另行指定的腮腺腺癌患者预后列线图的建立与验证:一项2004年至2016年的监测、流行病学和最终结果(SEER)分析
Front Surg. 2022 Jan 11;8:799452. doi: 10.3389/fsurg.2021.799452. eCollection 2021.
6
Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma.治疗前血清白蛋白作为头颈部腺样囊性癌的预后指标
Biomedicines. 2022 Jan 17;10(1):191. doi: 10.3390/biomedicines10010191.
7
The efficacy of iodine-125 interstitial brachytherapy for the treatment of locally advanced adenoid cystic carcinoma of the base of tongue: a non-surgical approach.碘-125 组织间近距离放射疗法治疗局部晚期舌根腺样囊性癌的疗效:一种非手术方法
J Contemp Brachytherapy. 2021 Aug;13(4):395-401. doi: 10.5114/jcb.2021.108593. Epub 2021 Aug 24.
8
Nomograms predictive for oncological outcomes in malignant parotid tumours: recurrence and mortality rates of 228 patients from a single institution.预测腮腺恶性肿瘤患者肿瘤学结局的列线图:来自单一机构的 228 例患者的复发率和死亡率。
Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4491-4503. doi: 10.1007/s00405-019-05556-9. Epub 2019 Jul 25.
9
Spinal Metastases from Adenoid Cystic Carcinoma of the Parotid Gland.腮腺腺样囊性癌的脊柱转移
Chin Med J (Engl). 2018 Nov 5;131(21):2616-2617. doi: 10.4103/0366-6999.244125.
10
Cervical lymph node metastases in salivary gland adenoid cystic carcinoma: a systematic review and meta-analysis.涎腺腺样囊性癌的颈部淋巴结转移:一项系统评价和荟萃分析。
Cancer Manag Res. 2018 Jun 22;10:1677-1685. doi: 10.2147/CMAR.S164677. eCollection 2018.